-
.
.
- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
$17
OFF DEAL
OFF DEAL
GET DEAL
218 Used Today
254 Used Today
80 Used Today
99 Used Today
Discount $10 On Your First Purchases Of $40 Or More
77 Used Today
110 Used Today
323 Used Today
treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk. .
218 Used Today